In addition, the authors highlighted the synergistic effects of oxaliplatin and the ATR inhibitor VE-822 in many colorectal cancer cell lines, demonstrating the occurrence of cytosolic DNA release, CD8 + T cell infiltration and reduced tumour growth in immune competent mice [149]. The gene discussed is CD8A; the disease is neoplasm.